C-Peptide as a Therapy for Type 1 Diabetes Mellitus.

Washburn RL, Mueller K, Kaur G, Moreno T, Moustaid-Moussa N, Ramalingam L, Dufour JM

Open source

DOI
10.3390/biomedicines9030270
Published
2021 Mar 8
Container
Biomedicines
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/biomedicines9030270,
  title = {C-Peptide as a Therapy for Type 1 Diabetes Mellitus.},
  author = {Washburn RL and Mueller K and Kaur G and Moreno T and Moustaid-Moussa N and Ramalingam L and Dufour JM},
  year = {2021},
  journal = {Biomedicines},
  doi = {10.3390/biomedicines9030270},
  url = {https://doi.org/10.3390/biomedicines9030270}
}

RIS

TY  - JOUR
TI  - C-Peptide as a Therapy for Type 1 Diabetes Mellitus.
AU  - Washburn RL
AU  - Mueller K
AU  - Kaur G
AU  - Moreno T
AU  - Moustaid-Moussa N
AU  - Ramalingam L
AU  - Dufour JM
PY  - 2021
JO  - Biomedicines
DO  - 10.3390/biomedicines9030270
UR  - https://doi.org/10.3390/biomedicines9030270
ER  - 

APA

RL, W., K, M., G, K., T, M., N, M., L, R., & JM, D. (2021). C-Peptide as a Therapy for Type 1 Diabetes Mellitus.. Biomedicines. https://doi.org/10.3390/biomedicines9030270

Source records